BPP, a dual functional inhibitor, targets MLL-rearranged acute myeloid leukemia: Unraveling mechanisms and expanding therapeutic horizons

被引:0
|
作者
Chen, Tai-Lin
Su, Tsann-Long
Lee, Te-Chang
机构
关键词
D O I
10.1158/1538-7445.AM2024-3330
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3330
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Therapeutic targeting potential of chromatin-associated proteins in MLL-rearranged acute leukemia
    Xu, Xin
    Schneider, Bjoern
    CELLULAR ONCOLOGY, 2019, 42 (02) : 117 - 130
  • [22] Therapeutic targeting potential of chromatin-associated proteins in MLL-rearranged acute leukemia
    Xin Xu
    Björn Schneider
    Cellular Oncology, 2019, 42 : 117 - 130
  • [23] Dual PI3K/mTOR inhibition shows antileukemic activity in MLL-rearranged acute myeloid leukemia
    Sandhoefer, N.
    Metzeler, K. H.
    Rothenberg, M.
    Herold, T.
    Tiedt, S.
    Groiss, V.
    Carlet, M.
    Walter, G.
    Hinrichsen, T.
    Wachter, O.
    Grunert, M.
    Schneider, S.
    Subklewe, M.
    Dufour, A.
    Froehling, S.
    Klein, H-G
    Hiddemann, W.
    Jeremias, I.
    Spiekermann, K.
    LEUKEMIA, 2015, 29 (04) : 828 - 838
  • [24] Dual PI3K/mTOR inhibition shows antileukemic activity in MLL-rearranged acute myeloid leukemia
    N Sandhöfer
    K H Metzeler
    M Rothenberg
    T Herold
    S Tiedt
    V Groiß
    M Carlet
    G Walter
    T Hinrichsen
    O Wachter
    M Grunert
    S Schneider
    M Subklewe
    A Dufour
    S Fröhling
    H-G Klein
    W Hiddemann
    I Jeremias
    K Spiekermann
    Leukemia, 2015, 29 : 828 - 838
  • [25] Distinct pathways affected by menin versus MLL1/MLL2 in MLL-rearranged acute myeloid leukemia
    Chen, Yufei
    Jones, Kenneth L.
    Anastassiadis, Konstantinos
    Kranz, Andrea
    Stewart, A. Francis
    Grembecka, Jolanta
    Meyerson, Matthew
    Ernst, Patricia
    EXPERIMENTAL HEMATOLOGY, 2019, 69 : 37 - 42
  • [26] UNRAVELING THE MECHANISMS UNDERLYING THE REFRACTORINESS OF MLL-REARRANGED ACUTE B-CELL LEUKEMIAS TO REPROGRAMMING INTO PLURIPOTENCY
    Bueno, Clara
    Romero-Moya, Damia
    Munoz-Lopez, Alvaro
    van Roon, E.
    Ramos, V.
    Agraz, A.
    Varela, I.
    Ariza, L.
    Castano, J.
    Giorgetti, A.
    Fernandez, A.
    Bardini, M.
    Fraga, M.
    Stam, Ronald
    Menendez, Pablo
    Ford, A.
    Lako, M.
    Granada, I.
    Colomer, D.
    Cazzaniga, G.
    Carvajal, X.
    Nakanishi, Mahito
    EXPERIMENTAL HEMATOLOGY, 2015, 43 (09) : S54 - S54
  • [27] Bet Inhibition as a Novel Therapeutic Approach for the Treatment of MLL-Rearranged Acute Lymphoblastic Leukemia in Infants
    Bardini, M.
    Trentin, L.
    Rizzo, F.
    Vieri, M.
    Savino, A. M.
    Fazio, G.
    Geertruy, T. K.
    Basso, G.
    Cazzaniga, G.
    Biondi, A.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S101 - S101
  • [28] The HOXA/PBX3 Pathway Is an Attractive Therapeutic Target in MLL-Rearranged Acute Leukemia
    Li, Zejuan
    Zhang, Zhiyu
    Li, Yuanyuan
    Arnovitz, Stephen
    Chen, Ping
    Huang, Hao
    Jiang, Xi
    Hong, Gia-Ming
    He, Chunjiang
    Wang, Chong-Zhi
    Elkahloun, Abdel
    Valk, Peter J. M.
    Dohner, Konstanze
    Neilly, Mary Beth
    Bullinger, Lars
    Delwel, Ruud
    Lowenberg, Bob
    Liu, Pu Paul
    Morgan, Richard
    Rowley, Janet D.
    Yuan, Chun-Su
    Chen, Jianjun
    BLOOD, 2012, 120 (21)
  • [29] Transcription factor MEF2D is required for the maintenance of MLL-rearranged acute myeloid leukemia
    Zhao, Lianzhong
    Zhang, Pengcheng
    Galbo, Phillip M.
    Zhou, Xinyue
    Aryal, Sajesan
    Qiu, Shaowei
    Zhang, Hao
    Zhou, Yang
    Li, Chunliang
    Zheng, Deyou
    Bhatia, Ravi
    Lu, Rui
    BLOOD ADVANCES, 2021, 5 (22) : 4727 - 4740
  • [30] Id2 and E Proteins Orchestrate the Initiation and Maintenance of MLL-Rearranged Acute Myeloid Leukemia
    Ghisi, Margherita
    Kats, Lev
    Masson, Frederick
    Li, Jason
    Kratina, Tobias
    Vidacs, Eva
    Gilan, Omer
    Doyle, Maria A.
    Newbold, Andrea
    Bolden, Jessica E.
    Fairfax, Kirsten A.
    de Graaf, Carolyn A.
    Firth, Matthew
    Zuber, Johannes
    Dickins, Ross A.
    Corcoran, Lynn M.
    Dawson, Mark A.
    Belz, Gabrielle T.
    Johnstone, Ricky W.
    CANCER CELL, 2016, 30 (01) : 59 - 74